Home  |  Contact

UniProtKB/Swiss-Prot P03915: Variant p.Ala236Thr

NADH-ubiquinone oxidoreductase chain 5
Gene: MT-ND5
Variant information

Variant position:  236
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LP/P [Disclaimer]
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Alanine (A) to Threonine (T) at position 236 (A236T, p.Ala236Thr).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from small size and hydrophobic (A) to medium size and polar (T)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  0
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  In MELAS.
Any additional useful information about the variant.

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  236
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  603
The length of the canonical sequence.

Location on the sequence:   LLLAAAGKSAQLGLHPWLPS  A MEGPTPVSALLHSSTMVVAG
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         LLLAAAGKSAQLGLHPWLPSAMEGPTPVSALLHSSTMVVAG

Gorilla                       FLLAAAGKSAQLGLHPWLPSAMEGPTPVSALLHSSTMVVAG

                              LLLAATGKSAQFGLHPWLPSAMEGPTPVSALLHSSTMVVAG

Chimpanzee                    FLLAAAGKSAQLGLHPWLPSAMEGPTPVSALLHSSTMVVAG

Mouse                         LLIAATGKSAQFGLHPWLPSAMEGPTPVSALLHSSTMVVAG

Rat                           LLIAATGKSAQFGLHPWLPSAMEGPTPVSALLHSSTMVVAG

Pig                           LLLAAAGKSAQFGLHPWLPSAMEGPTPVSALLHSSTMVVAG

Bovine                        LALAATGKSAQFGLHPWLPSAMEGPTPVSALLHSSTMVVAG

Rabbit                        LILAATGKSAQFGLHPWLPSAMEGPTPVSALLHSSTMVVAG

Sheep                         LILAATGKSAQFGLHPWLPSAMEGPTPVSALLHSSTMVVAG

Cat                           LLLAATGKSAQFGLHPWLPSAMEGPTPVSALLHSSTMVVAG

Horse                         LLLAATGKSAQFGLHPWLPSAMEGPTPVSALLHSSTMVVAG

Chicken                       LILAATGKSAQFGLHPWLPAAMEGPTPVSALLHSSTMVVAG

                              FLLAAAGKSAQLGLHPWLPSAMEGPTPVSALLHSSTMVVAG

Xenopus laevis                LILAATGKSAQFGLHPWLPAAMEGPTPVSALLHSSTMVVAG

Zebrafish                     LIIAATGKSAQFTLHPWLPSAMEGPTPVSALLHSSTMVVAG

Caenorhabditis elegans        LLLTAFTKSAQFPFSSWLPKAMSAPTPVSSLVHSSTLVTAG

Drosophila                    VMLAAMTKSAQIPFSSWLPAAMAAPTPVSALVHSSTLVTAG

Slime mold                    IVIGVVGKSAQLGLHMWLPDAMEGPTPVSALLHAATMVTAG

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 1 – 603 NADH-ubiquinone oxidoreductase chain 5


Literature citations

Novel mitochondrial DNA ND5 mutation in a patient with clinical features of MELAS and MERRF.
Naini A.B.; Lu J.; Kaufmann P.; Bernstein R.A.; Mancuso M.; Bonilla E.; Hirano M.; DiMauro S.;
Arch. Neurol. 62:473-476(2005)
Cited for: VARIANT MELAS THR-236;

Mutations in the ND5 subunit of complex I of the mitochondrial DNA are a frequent cause of oxidative phosphorylation disease.
Blok M.J.; Spruijt L.; de Coo I.F.M.; Schoonderwoerd K.; Hendrickx A.; Smeets H.J.;
J. Med. Genet. 44:E74-E74(2007)
Cited for: VARIANTS MELAS THR-236 AND ASN-393;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.